Patents Represented by Attorney Stuart L. Melton
  • Patent number: 4424213
    Abstract: Novel heterobicyclic compounds of Formula I, processes for preparing same and pesticidal compositions and methods are described.
    Type: Grant
    Filed: November 2, 1981
    Date of Patent: January 3, 1984
    Assignee: SDS Biotech Corporation
    Inventors: Thomas A. Magee, Robert D. Battershell, Lawrence E. Limpel, Andrew W. Ho, Arthur W. Friedman, H. Glenn Corkins, William W. Brand, Russell Buchman, Louis Storace, Edmond R. Osgood
  • Patent number: 4310551
    Abstract: Substituted 1,2,4-triazines, compositions thereof and methods of using same are described. The compounds of the invention exhibit a wide range of pharmacological activity including anti-inflammatory, analgesic, anti-pyretic, hypotensive and central nervous system effects.
    Type: Grant
    Filed: November 14, 1980
    Date of Patent: January 12, 1982
    Assignee: Diamond Shamrock Corporation
    Inventors: James M. Gullo, William P. Heilman, Robert J. Wayner, Robert E. Moser
  • Patent number: 4286091
    Abstract: Valuable pyridazinone intermediates to pharmaceutically useful compounds can be prepared in surprisingly high yields by the reaction of the corresponding monohydrazone with diketene, preferably in the presence of a basic catalyst. In an especially preferred embodiment, p,p'-dichlorobenzil monohydrazone and diketene are reacted in a xylene solvent in the presence of triethylamine to afford 4-acetyl-5,6-bis(p-chlorophenyl)-2H-pyridazin-3-one, which can then be reacted with ethylene carbonate in the presence of potassium carbonate to afford the antihypertensive agent, 4-acetyl-5,6-bis(p-chlorophenyl)-2-(2'-hydroxyethyl)-2H-pyridazine-3-one.
    Type: Grant
    Filed: May 19, 1980
    Date of Patent: August 25, 1981
    Assignee: Diamond Shamrock Corporation
    Inventors: Russell M. Bimber, Russell Buchman, Michael F. DePompei, Larry J. Powers
  • Patent number: 4281125
    Abstract: Valuable pyridazinone intermediates to pharmaceutically useful compounds can be prepared in surprisingly high yields by the quinoline catalyzed reaction of the corresponding monohydrazone with an appropriately substituted acetic acid ester. In an especially preferred embodiment, p,p'-dichlorobenzil monohydrazone and methyl acetoacetate are reacted in a xylene solvent in the presence of quinoline to afford 4-acetyl-5,6-bis(p-chlorophenyl)-2H-pyridazin-3-one, which can then be reacted with ethylene carbonate in the presence of potassium carbonate to afford the antihypertensive agent, 4-acetyl-5,6-bis(p-chlorophenyl)-2-(2'-hydroxyethyl)-2H-pyridazin-3-one.
    Type: Grant
    Filed: May 15, 1980
    Date of Patent: July 28, 1981
    Assignee: Diamond Shamrock Corporation
    Inventors: Michael F. DePompei, Alex Hlynsky
  • Patent number: 4258715
    Abstract: Improved shaped polymeric articles, including ostomy seals, are obtained by radiation crosslinking an acrylamide polymer composition comprising a water-soluble acrylamide polymer plasticized with a quantity of a water-miscible polyol (containing water) that provides a soft, flexible and elastomeric composition.
    Type: Grant
    Filed: December 8, 1978
    Date of Patent: March 31, 1981
    Assignee: Diamond Shamrock Corporation
    Inventor: Paul H. Goble
  • Patent number: 4254008
    Abstract: An improved ostomy seal is provided by a crosslinked composition comprising a water-soluble acrylamide polymer, a plasticizing quantity of a water-miscible polyol (containing water) that provides an elastomeric gel, and a crosslinking polyaldehyde.
    Type: Grant
    Filed: September 13, 1979
    Date of Patent: March 3, 1981
    Assignee: Diamond Shamrock Corporation
    Inventor: George Krsek
  • Patent number: 4251527
    Abstract: Substituted 1,2,4-triazines, compositions thereof and methods of using same are described. The compounds of the invention exhibit a wide range of pharmacological activity including anti-inflammatory, analgesic, anti-pyretic, hypotensive and central nervous system effects.
    Type: Grant
    Filed: March 19, 1979
    Date of Patent: February 17, 1981
    Assignee: Diamond Shamrock Corporation
    Inventors: James M. Gullo, William P. Heilman, Robert J. Wayner, Robert E. Moser
  • Patent number: 4238490
    Abstract: Compounds of the formula ##STR1## are useful antihypertensive agents.
    Type: Grant
    Filed: February 12, 1979
    Date of Patent: December 9, 1980
    Assignee: Diamond Shamrock Corporation
    Inventors: Larry J. Powers, Zaven S. Ariyan, Russell Buchman, James A. Scozzie, Robert E. Moser, William J. Pyne
  • Patent number: 4238219
    Abstract: A composition consisting essentially of 2-chloroethylphosphonic acid and certain imides, carbamates, or tetrachloroisophthalonitrile, increases the ability of 2-chloroethylphosphonic acid alone to cause the release of ethylene in plant tissue when applied to same.
    Type: Grant
    Filed: February 21, 1978
    Date of Patent: December 9, 1980
    Assignee: Diamond Shamrock Corporation
    Inventors: Robert E. Holm, Han San Ku
  • Patent number: 4224334
    Abstract: Certain imidazothiazoles and thiazolopyrimidines have been found to prevent and inhibit the formation of granuloma tissue in animals. This result is accomplished by administering to the animal subject a therapeutically effective amount of a compound having the formula: ##STR1## wherein R is hydrogen or methyl, R' is hydrogen, lower alkyl or thioalkyl, carboxy methyl, or phenyl; R" is lower alkyl, 2-benzofuranyl, naphthyl, phenyl, or mono- or disubstituted phenyl. The hydrated precursors of certain of these compounds as well as the acid addition and quaternary salts of both the compounds and their hydrated precursors may be employed.
    Type: Grant
    Filed: April 2, 1979
    Date of Patent: September 23, 1980
    Assignee: Diamond Shamrock Corporation
    Inventors: Robert E. Moser, Larry J. Powers, Zaven S. Ariyan
  • Patent number: 4185630
    Abstract: Ostomy collection pouch appliances suitable for operation in a first, non-vented, or second, vented but substantially leak-proof, mode and provided with a sealed port member including a heat seal configuration which provides the user with directional information concerning proper opening of the port.
    Type: Grant
    Filed: August 15, 1977
    Date of Patent: January 29, 1980
    Assignee: Diamond Shamrock Corporation
    Inventors: Erich Neumeier, Douglas J. Marver
  • Patent number: 4160768
    Abstract: Certain imidazothiazoles and thiazolopyrimidines have been found to prevent and inhibit the formation of granuloma tissue in animals. This result is accomplished by administering to the animal subject a therapeutically effective amount of a compound having the formula: ##STR1## WHEREIN R is hydrogen or methyl, R' is hydrogen, lower alkyl or thioalkyl, carboxy methyl, or phenyl; R" is lower alkyl, 2-benzofuranyl, naphthyl, phenyl, or mono- or disubstituted phenyl. The hydrated precursors of certain of these compounds as well as the acid addition and quaternary salts of both the compounds and their hydrated precursors may be employed.
    Type: Grant
    Filed: March 2, 1978
    Date of Patent: July 10, 1979
    Assignee: Diamond Shamrock Corporation
    Inventors: Robert E. Moser, Larry J. Powers, Zaven S. Ariyan
  • Patent number: 4157392
    Abstract: Substituted 1,2,4-triazines, compositions thereof and methods of using same are described. The compounds of the invention exhibit a wide range of pharmacological activity including anti-inflammatory, analgesic, anti-pyretic, hypotensive and central nervous system effects.
    Type: Grant
    Filed: April 19, 1978
    Date of Patent: June 5, 1979
    Assignee: Diamond Shamrock Corporation
    Inventors: James M. Gullo, William P. Heilman, Robert J. Wayner, Robert E. Moser
  • Patent number: 4145209
    Abstract: A composition comprising two compounds from the group cycloheximide, 5-chloro-3-methyl-4-nitro-1H-pyrazole and glyoxal dioxime and optionally including an additive compound capable of enhancing the activity of the composition is a synergistic combination capable of promoting fruit, especially citrus fruit, abscission when applied to trees bearing same.
    Type: Grant
    Filed: February 7, 1977
    Date of Patent: March 20, 1979
    Assignee: Diamond Shamrock Corporation
    Inventor: Robert E. Holm
  • Patent number: 4110451
    Abstract: Certain imidazothiazoles and thiazolopyrimidines have been found to prevent and inhibit the formation of granuloma tissue in animals. This result is accomplished by administering to the animal subject a therapeutically effective amount of a compound having the formula: ##STR1## wherein R is hydrogen or methyl, R' is hydrogen, lower alkyl or thioalkyl, carboxy methyl, or phenyl; R" is lower alkyl, 2-benzofuranyl, naphthyl, phenyl, or mono- or disubstituted phenyl. The hydrated precursors of certain of these compounds as well as the acid addition and quaternary salts of both the compounds and their hydrated precursors may be employed.
    Type: Grant
    Filed: December 29, 1976
    Date of Patent: August 29, 1978
    Assignee: Diamond Shamrock Corporation
    Inventors: Robert E. Moser, Larry J. Powers, Zaven S. Ariyan
  • Patent number: 4105434
    Abstract: Herbicidally active 5,5'-bis-1,2,4-triazinyl compounds, compositions and methods of using same to control undesired vegetation.
    Type: Grant
    Filed: January 17, 1977
    Date of Patent: August 8, 1978
    Assignee: Diamond Shamrock Corporation
    Inventors: William W. Paudler, Robert E. Moser, Norman M. Pollack
  • Patent number: 4103016
    Abstract: Certain imidazothiazoles and thiazolopyrimidines have been found to prevent and inhibit the formation of granuloma tissue in animals. This result is accomplished by administering to the animal subject a therapeutically effective amount of a compound having the formula: ##STR1## wherein R is hydrogen or methyl, R' is hydrogen, lower alkyl or thioalkyl, carboxy methyl, or phenyl; R" is lower alkyl, 2-benzofuranyl, naphthyl, phenyl, or mono- or disubstituted phenyl. The hydrated precursors of certain of these compounds as well as the acid addition and quaternary salts of both the compounds and their hydrated precursors may be employed.
    Type: Grant
    Filed: December 22, 1976
    Date of Patent: July 25, 1978
    Assignee: Diamond Shamrock Corporation
    Inventors: Robert E. Moser, Larry J. Powers, Zaven S. Ariyan
  • Patent number: 4090863
    Abstract: A combination of 5-chloro-3-methyl-4-nitro-1H-pyrazole and certain imides, carbamates, or a phthalonitrile is a synergistic composition capable of promoting fruit, especially citrus fruit, abscission when applied to trees bearing same.
    Type: Grant
    Filed: August 11, 1975
    Date of Patent: May 23, 1978
    Assignee: Diamond Shamrock Corporation
    Inventor: Robert E. Holm
  • Patent number: 4073637
    Abstract: A combination of cycloheximide and certain imides or carbamates is a synergistic composition capable of promoting fruit, especially citrus fruit, abscission when applied to trees bearing same.
    Type: Grant
    Filed: August 11, 1975
    Date of Patent: February 14, 1978
    Assignee: Diamond Shamrock Corporation
    Inventors: Robert E. Holm, Robert D. Battershell
  • Patent number: 4041167
    Abstract: Certain imidazothiazoles and thiazolopyrimidines have been found to prevent and inhibit the formation of granuloma tissue in animals. This result is accomplished by administering to the animal subject a therapeutically effective amount of a compound having the formula: ##STR1## wherein R is hydrogen or methyl, R' is hydrogen, lower alkyl or thioalkyl, carboxy methyl, or phenyl; R" is lower alkyl, 2-benzofuranyl, naphthyl, phenyl, or mono- or disubstituted phenyl. The hydrated precursors of certain of these compounds as well as the acid addition and quaternary salts of both the compounds and their hydrated precursors may be employed.
    Type: Grant
    Filed: January 19, 1976
    Date of Patent: August 9, 1977
    Assignee: Diamond Shamrock Corporation
    Inventors: Robert E. Moser, Larry J. Powers, Zaven S. Ariyan